Mark Stencik is the Associate Vice President and Head of Transactions at Merck, leading the transactions groups for the Boston and London Innovation Hubs. They focus on business development for early-stage therapeutic opportunities, aiming to enhance the Merck pipeline through collaboration, licensing, and mergers and acquisitions. Previously, they held positions at Vertex Pharmaceuticals as Director of Business Development and Strategic Operations, at Amgen Inc. as Senior Manager of Business Development and Strategy, and at CameraPlanet.com as Vice President of Finance. Mark studied accounting at Pennsylvania State University and earned an MBA in Finance from NYU Stern School of Business.
This person is not in the org chart
This person is not in any teams
This person is not in any offices